Citicoline IV Infusion — 1 Ampule

A single-ampule intravenous citicoline infusion delivered at Doktor Brno's supervised medical facility on Masarykova in central Brno. Citicoline (CDP-choline) is a naturally occurring brain compound that serves as a precursor to both phosphatidylcholine — the primary phospholipid in neuronal membranes — and acetylcholine, a key neurotransmitter for memory and attention. IV delivery achieves full systemic bioavailability, bypassing the conversion losses inherent in oral supplementation. The clinic's evidence base cites improvements in memory, attention, information processing speed, comprehension, and spatial orientation, with a neuroprotective profile relevant to age-related cognitive decline, concentration issues, and post-neurological-event recovery.

Citicoline IV therapy at Doktor Brno uses a one-ampule dose of CDP-choline (cytidine 5'-diphosphocholine) delivered intravenously over 60–90 minutes. Citicoline is an endogenous compound found in all living cells; its primary roles are as a structural component of neuronal cell membranes (via its conversion to phosphatidylcholine) and as a precursor to acetylcholine synthesis. IV administration ensures 100% bioavailability — a significant advantage over oral supplementation, where the compound is hydrolysed to cytidine and choline before absorption and must be resynthesised. At Doktor Brno, citicoline infusions are positioned for cognitive support: the clinic's literature references improvements in memory (short-term and working memory), sustained attention, information processing speed, verbal comprehension, and spatial orientation. The neuroprotective aspect is relevant to patients managing early cognitive decline, chronic stress-related concentration impairment, post-stroke or post-TIA recovery (under neurologist co-management), and occupational fatigue in knowledge-intensive professions. The first session begins with a physician consultation to review the patient's medical history, neurological background, and current medications — particularly cholinergic drugs or supplements that might interact. From the second session onward, the patient proceeds directly to infusion at the reduced per-session rate. The nurse places the IV line and the drip runs for approximately 60–90 minutes under clinical supervision. No driving restrictions or recovery period are imposed post-infusion. The one-ampule dose is the entry-level citicoline protocol, suitable for patients new to this therapy or those with mild-to-moderate cognitive support needs. For patients requiring a more intensive course — or where the physician assesses that a higher dose is clinically appropriate — the two-ampule option (listed separately) delivers double the dose per session. A structured course of 5–10 sessions is typically recommended for cognitive-support applications, and the clinic's pack pricing reflects this. The 10-session pack at 4,300 CZK brings the per-session cost to 430 CZK — around the price of a pharmacist's supply of oral CDP-choline for a month, but with the bioavailability advantage of IV delivery. Sessions can be spaced weekly or twice-weekly depending on clinical recommendation and the patient's schedule.